Xoma reported $-4767000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Agenus AGEN:US $ -44.56M 9.1M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Ardelyx ARDX:US $ -26.22M 1.59M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Celldex Therapeutics CLDX:US $ -36.4M 13.14M
Chimerix CMRX:US -23447000 1.32M
Curis CRIS:US $ -15.06M 0.07M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Emergent Biosolutions EBS:US $ -72M 78.4M
Epizyme EPZM:US $ -29806000 21.12M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Life Technologies LIFE:US $ -12.58M 0.21M
Macrogenics MGNX:US $ -41808000 24.83M
Novartis NVS:US $ 2228M 624M
Novartis NOVN:VX 2.23B 624M
Pfizer PFE:US $ 12102M 2229M
Prothena PRTA:US -43209000 5.26M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
Xoma XOMA:US $ -4767000 2.7M
YTE INCY:US $ 254.43M 137.89M